Abacus Life (ABL) 10-K/A 16 Jul 21 2020 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	7 Months Ended
	Dec. 31, 2020	Jul. 16, 2021	Jun. 30, 2020
Document Information [Line Items]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	East Resources Acquisition Company (the “Company,” “we”, “our” or “us”) is filing this Annual Report on Form 10-K/A (“Amendment No. 1” or this “Amendment”), to amend our Annual Report on Form 10-K for the year ended December 31, 2020, originally filed with the Securities and Exchange Commission, or the SEC, on March 26, 2021 (the “Original Filing”), to restate our financial statements as of and for the period ended December 31, 2020. We are also restating the financial statements as of July 27, 2020 and as of and for the period ended September 30, 2020 in the accompanying financial statements included in this Annual Report (collectively, the “Original Financial Statements”). The restatement primarily relates to consideration of the factors in determining whether to classify contracts that may be settled in an entity’s own stock as equity of the entity or as an asset or liability in accordance with Accounting Standards Codification (“ASC”) 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity. In the Original Financial Statements, the Company classified the public warrants and private placement warrants issued in connection with the Company’s initial public offering (the “Warrants”) as equity instruments. Upon further consideration of the rules and guidance, management of the Company concluded that the Warrants are precluded from equity classification. As a result, the Warrants should be recorded as liabilities on the balance sheet and measured at fair value at inception and on a recurring basis in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations. In the process of evaluating its financial statements we also reassessed the accounting for our forward purchase agreement and determined that the obligation to issue FPA Shares and FPA Warrants represents a forward contract that meets the definition of derivative liability in accordance with ASC 815-40. Based on this reassessment, we determined that the forward contract should be classified as a liability measured at fair value upon issuance, with subsequent changes in fair value reported in our Statement of Operations each reporting period. The Company also restated its financial statements to classify all Class A common stock in temporary equity. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, Distinguishing Liabilities from Equity – SEC Materials (“ASC 480-10-S99”), redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. The Company had previously classified 1,636,578 shares in permanent equity. Although the Company did not specify a maximum redemption threshold, its charter provides that currently, the Company will not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001. The Company restated its financial statements to classify all Class A common stock as temporary equity and any related impact, as the threshold in its charter would not change the nature of the underlying shares as redeemable and thus would be required to be disclosed outside of permanent equity. As a result, on May 18, 2021, after consultation with the Company’s board of directors, management concluded that the Original Financial Statements should no longer be relied upon and are to be restated in order to correct the classification error. The Company’s accounting for the Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported investments held in trust, cash flows or cash. The Company has not amended its Current Report on Form 8-K filed on July 31, 2020 for the period affected by the restatement. The financial information that has been previously filed or otherwise reported is superseded by the information in this Amendment, and the financial statements and related financial information contained in such previously filed report should no longer be relied upon. The restatement is more fully described in Note 2 of the notes to the financial statements included herein. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by the Company’s principal executive officer and principal financial officer are filed as exhibits (in Exhibits 31.1 and 32.1) to this Amendment under Item 15 of Part IV hereof. Except as described above, this Amendment does not amend, update or change any other items or disclosures contained in the Original Filing, and accordingly, this Amendment does not reflect or purport to reflect any information or events occurring after the original filing date or modify or update those disclosures affected by subsequent events. Accordingly, this Amendment should be read in conjunction with the Original Filing and the Company’s other filings with the SEC. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Original Filing.
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Registrant Name	East Resources Acquisition Company
Entity Central Index Key	0001814287
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Public Float			$ 0
Entity Shell Company	true
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity File Number	001-39403
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-1210472
Entity Address, Address Line One	7777 NW Beacon Square Boulevard
Entity Address, City or Town	Boca Raton
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33487
City Area Code	561
Local Phone Number	826-3620
Document Annual Report	true
Document Transition Report	false
Class A common stock
Document Information [Line Items]
Entity Common Stock Shares Outstanding		34,500,000
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	ERES
Security Exchange Name	NASDAQ
Class A common stock | One-Half of One Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-half of one warrant
Trading Symbol	ERESU
Security Exchange Name	NASDAQ
Class A common stock | Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Trading Symbol	ERESW
Security Exchange Name	NASDAQ
Class B common stock
Document Information [Line Items]
Entity Common Stock Shares Outstanding		8,625,000

BALANCE SHEET

BALANCE SHEET	Dec. 31, 2020USD ($)
Current Assets
Cash	$ 589,685
Prepaid expenses	234,750
Total Current Assets	824,435
Marketable securities held in Trust Account	345,026,104
TOTAL ASSETS	345,850,539
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities - accrued expenses	141,315
Forward purchase agreement liability	2,900,000
Warrant liability	29,811,000
Deferred underwriting payable	12,075,000
Total Liabilities	44,927,315
Commitments
Stockholders’ Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital	24,137
Accumulated deficit	(44,101,776)
Total Stockholders’ Deficit	(44,076,776)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	345,850,539
Class A common stock
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Redemption value	345,000,000
Class B common stock
Stockholders’ Deficit
Common stock value	863
Total Stockholders’ Deficit	$ 863

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical)	Dec. 31, 2020$ / sharesshares
Preferred stock, par value | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A common stock
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	200,000,000
Common stock, shares, issued	0
Common stock, shares, outstanding	0
Redemption stock	34,500,000
Class B common stock
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	20,000,000
Common stock, shares, issued	8,625,000
Common stock, shares, outstanding	8,625,000

CONDENSED STATEMENT OF OPERATIO

CONDENSED STATEMENT OF OPERATIONS	7 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Formation and operating costs	$ 476,742
Loss from operations	(476,742)
Other income (expenses):
Change in fair value of warrant liability	(7,583,500)
Change in fair value of forward purchase agreement liability	(1,900,000)
Transaction costs allocable to warrants	(861,354)
Interest earned - bank	33
Interest earned on marketable securities held in Trust Account	26,104
Other expenses, net	(10,318,717)
Loss before provision for income taxes	(10,795,459)
Net loss	$ (10,795,459)
Class A Common to Redemption
Other income (expenses):
Basic and diluted weighted average shares outstanding | shares	33,668,790
Basic and diluted net loss per share | $ / shares	$ 0
Non-redeemable Preferred Stock
Other income (expenses):
Basic and diluted weighted average shares outstanding | shares	8,145,740
Basic and diluted net loss per share | $ / shares	$ (1.33)

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDER'S EQUITY - 7 months ended Dec. 31, 2020 - USD ($)	Total	Class A common stock	Class B common stock	Additional Paid-in Capital	Accumulated Deficit
Balance at May. 21, 2020
Balance, shares at May. 21, 2020
Issuance of Class B common stock to Sponsor	25,000		$ 863	24,137
Issuance of Class B common stock to Sponsors, shares			8,625,000
Sale of 34,500,000 Units, net of underwriting Discounts, offering costs, Public Warrant liability and FPA liability	$ 310,358,683	$ 3,450		310,355,233
Sale of 34,500,000 Units, net of underwriting Discounts, offering costs and Public Warrant liability and FPA liability,shares	34,500,000	34,500,000
Sale of 8,900,000 Private Placement Warrants	$ 1,335,000			1,335,000
Class A common stock subject to possible redemption	(345,000,000)	$ (3,450)		(311,690,233)	(33,306,317)
Class A common stock subject to possible redemption, shares		(34,500,000)
Net loss	(10,795,459)				(10,795,459)
Balance at Dec. 31, 2020	$ (44,076,776)		$ 863	$ 24,137	$ (44,101,776)
Balance, shares at Dec. 31, 2020			8,625,000

STATEMENT OF CHANGES IN STOCK_2

STATEMENT OF CHANGES IN STOCKHOLDER'S EQUITY (Parenthetical)	7 Months Ended
	Dec. 31, 2020shares
Sale of units, net of underwriting discounts, offering costs and public warranty	34,500,000
Private Placement Warrants | Warrants
Sale of warrants	8,900,000

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS	7 Months Ended
	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (10,795,459)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liability	7,583,500
Change in fair value of forward purchase agreement liability	1,900,000
Transaction costs allocable to warrants	861,354
Interest earned on marketable securities held in Trust Account	(26,104)
Changes in operating assets and liabilities:
Prepaid expenses	(234,750)
Accrued expenses	141,315
Net cash used in operating activities	(570,144)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(345,000,000)
Net cash used in investing activities	(345,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	338,100,000
Proceeds from sale of Private Placement Warrants	8,900,000
Advances from related party	265,763
Repayment of advances from related party	(265,763)
Proceeds from promissory note – related party	97,126
Repayment of promissory note – related party	(97,126)
Payment of offering costs	(865,171)
Net cash provided by financing activities	346,159,829
Net Change in Cash	589,685
Cash – End of period	589,685
Non-Cash investing and financing activities:
Deferred underwriting fee payable	12,075,000
Class A common stock
Non-Cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption	$ 345,000,000

Description of Organization and

Description of Organization and Business Operations	7 Months Ended
	Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS East Resources Acquisition Company (the “Company”) is a newly organized blank check company incorporated in Delaware on May 22, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus its search for a target business in the energy industry in North America. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from May 22, 2020 (inception) through December 31, 2020 relates to the Company's formation, its initial public offering ("Initial Public Offering"), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on July 22, 2020. On July 27, 2020, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 8,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to East Sponsor, LLC (the “Sponsor”), generating gross proceeds of $8,000,000, which is described in Note 5. On August 25, 2020, the underwriters exercised their over-allotment option in full, resulting in an additional 4,500,000 Units issued for total gross proceeds of $45,000,000. In connection with the underwriters’ exercise of their over-allotment option in full, the Company also consummated the sale of an additional 900,000 Private Placement Warrants at $1.00 per Private Placement Warrant, generating total proceeds of $900,000. A total of $45,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $345,000,000. Transaction costs amounted to $19,840,171, consisting of $6,900,000 of underwriting fees, $12,075,000 of deferred underwriting fees and $865,171 of other offering costs. Following the closing of the Initial Public Offering on July 27, 2020 and the exercise of the over-allotment option on August 25, 2020, an amount of $345,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting commissions held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon consummation of such Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares have agreed to vote their Founder Shares (as defined in Note 6) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive their redemption rights with respect to any such shares in connection with a stockholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination. Additionally, each public stockholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company's Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination. The Company will have until July 27, 2022 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Proposed Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent public accountants), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	7 Months Ended
	Dec. 31, 2020
Accounting Changes And Error Corrections [Abstract]
Restatement of Previously Issued Financial Statements	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 4) and Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the Warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender offer or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of stock, all holders of the Warrants would be entitled to receive cash for their Warrants (the “tender offer provision”). On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the Securities and Exchange Commission together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement. In further consideration of the SEC Statement, the Company’s management further evaluated the Warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the tender offer provision fails the “classified in stockholders’ equity” criteria as contemplated by ASC Section 815-40-25. As a result of the above, the Company should have classified the Warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the Warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported investments held in trust, operating expenses or cash. The table below summarizes the effects of the restatement on the financial statements for all periods being restated: As Previously As Reported Adjustments Restated Balance sheet as of July 27, 2020 (audited) Warrant Liability $ — $ 19,550,000 $ 19,550,000 Forward purchase agreement liability — 1,000,000 1,000,000 Class A Common Stock Subject to Possible Redemption 285,659,360 59,340,640 345,000,000 Class A Common Stock 143 (143 ) — Additional Paid-in Capital 4,999,463 (4,975,326 ) 24,137 Accumulated Deficit (468 ) (74,915,171 ) (74,915,639 ) Number of Class A common stock subject to possible redemption 28,565,936 5,934,064 34,500,000 Balance sheet as of September 30, 2020 (unaudited) Warrant Liability $ — $ 16,736,000 $ 16,736,000 Forward purchase agreement liability — 550,000 550,000 Class A Common Stock Subject to Possible Redemption 328,955,750 16,044,250 345,000,000 Class A Common Stock 160 (160 ) — Additional Paid-in Capital 5,128,056 (5,103,919 ) 24,137 Accumulated Deficit (129,076 ) (28,226,171 ) (28,355,247 ) Number of Class A common stock subject to possible redemption 32,895,575 1,604,425 34,500,000 Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 29,811,000 $ 29,811,000 Forward purchase agreement liability — 2,900,000 2,900,000 Class A Common Stock Subject to Possible Redemption 328,634,220 16,365,780 345,000,000 Class A Common Stock 164 (164 ) — Additional Paid-in Capital 5,449,582 5,425,445 24,137 Accumulated Deficit (450,605 ) (43,651,171 ) (44,101,776 ) Number of Class A common stock subject to possible redemption 32,863,422 1,636,578 34,500,000 Statement of Operations for period from May 22, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 5,491,500 $ 5,491,500 Change in fair value of forward purchase agreement liability $ — $ 450,000 $ 450,000 Transaction costs allocable to warrants $ — $ (861,354 ) $ (861,354 ) Net income (loss) $ (129,076 ) $ 5,080,146 $ 4,951,070 Weighted average shares outstanding of Class A redeemable common stock 30,971,013 1,521,295 32,492,308 Basic and diluted net income per share, Class A redeemable common stock $ 0.00 — $ 0.00 Weighted average shares outstanding of non-redeemable common stock 8,564,001 (754,841 ) 7,809,160 Basic and diluted net (loss) income per share, non-redeemable common stock $ (0.02 ) 0.65 $ 0.63 Statement of Operations for period from May 22, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ (7,583,500 ) $ (7,583,500 ) Change in fair value of forward purchase agreement liability $ — $ (1,900,000 ) $ (1,900,000 ) Transaction costs allocable to warrants $ — $ (861,354 ) $ (861,354 ) Net loss $ (450,605 ) $ (10,344,854 ) $ (10,795,459 ) Weighted average shares outstanding of Class A redeemable common stock 32,098,782 1,570,008 33,668,790 Basic and diluted net income per share, Class A redeemable common stock $ 0.00 — $ 0.00 Weighted average shares outstanding of non-redeemable common stock 9,251,082 (1,105,342 ) 8,145,740 Basic and diluted net loss per share, non-redeemable common stock $ (0.05 ) (1.28 ) $ (1.33 ) Statement of Cash Flows for period from May 22, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ (5,491,500 ) $ (5,491,500 ) Change in fair value of forward purchase agreement liability — (450,000 ) (450,000 ) Transaction costs allocable to warrants — 861,354 861,354 Net income (loss) (129,076 ) 4,080,146 4,951,070 Initial classification of Class A common stock subject to possible redemption 329,084,360 15,915,640 345,000,000 Change in value of common stock subject to possible redemption (128,610 ) 128,610 — Statement of Cash Flows for period from May 22, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ 7,583,500 $ 7,583,500 Change in fair value of forward purchase agreement liability — 1,900,000 1,900,000 Transaction costs allocable to warrants — 861,354 861,354 Net loss (450,605 ) (10,344,854 ) (10,795,459 ) Initial classification of Class A common stock subject to possible redemption 329,084,360 15,915,640 345,000,000 Change in value of common stock subject to possible redemption (450,140 ) 450,140 —

Summary of Significant Accounti

Summary of Significant Accounting Policies	7 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills. Class A Common Stock Subject to Possible Redemption The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. The Company’s derivative instruments are recorded at fair value and re-valued at each reporting date, with changes in the fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants and the forward contract for additional warrants are derivatives. As the financial instruments meet the definition of a derivative the warrants and the forward contract for additional warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the Statement of Operations in the period of change. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements. Net Loss per Common Share Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 26,150,000 shares in the calculation of diluted loss per share, since the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to possible redemption outstanding since original issuance. Net income (loss) per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of non-redeemable common stock outstanding for the period. Non-redeemable common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period from May 22, 2020 (Inception) Through December 31, 2020 Class A common stock subject to possible redemption Numerator: Earnings allocable to common stock subject to possible redemption Interest earned and unrealized gain $ 26,104 Less: interest available to be withdrawn for payment of taxes (26,104 ) Net income attributable to Class A common stock subject to $ — Denominator: Weighted Average Class A common stock subject to possible Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 33,668,790 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable common stock Numerator: Net Loss minus Net Earnings Net loss $ ( 10,795,459 ) Less: Net income allocable to Class A Common stock subject to possible redemption — Non-Redeemable Net Loss $ ( 10,795,459 ) Denominator: Weighted Average Non-Redeemable common stock Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,145,740 Basic and diluted net loss per share, Non-redeemable common stock $ ( 1.33 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Public Offering

Public Offering	7 Months Ended
	Dec. 31, 2020
Equity [Abstract]
PUBLIC OFFERING	NOTE 4. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 34,500,000 Units, which includes the full exercise by the underwriters of their over-allotment option on August 25, 2020, in the amount of 4,500,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant ("Public Warrant"). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9).

Private Placement

Private Placement	7 Months Ended
	Dec. 31, 2020
Equity [Abstract]
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 8,900,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $8,900,000. Each Private Placement Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9). The proceeds from the sale of the Private Placement Warrants will be added to the net proceeds from the Proposed Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Related Party Transactions

Related Party Transactions	7 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On June 1, 2020, the Sponsor purchased 8,625,000 shares (the “Founder Shares”) of the Company’s Class B common stock, par value $0.0001 per share (the “Class B common stock”), for an aggregate price of $25,000. The Founder Shares will automatically convert into Class A common stock on a one-for-one basis at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions. The Founder Shares included up to an aggregate of 1,125,000 shares subject to forfeiture to the extent that the over-allotment option was not exercised in full or in part by the underwriters so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option on August 25, 2020, 1,125,000 Founder Shares are no longer subject to forfeiture. Administrative Support Agreement The Company entered into an agreement, commencing on July 24, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay two affiliates of the Sponsor $10,000 each, per month, for office space and administrative support services. For the period from May 22, 2020 (inception) through December 31, 2020, the Company incurred and paid $105,161 in fees for these services. Advances from Related Party Affiliates of the Company and of the Sponsor advanced the Company an aggregate of $265,763 to cover expenses related to the Initial Public Offering. The advances were non-interest bearing and due on demand. The outstanding advances of $265,763 were repaid at the closing of the Initial Public Offering on July 27, 2020. Promissory Note — Related Party On June 24, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the "Note"). The Note was non-interest bearing and payable on the earlier of August 31, 2020 or the completion of the Initial Public Offering. The outstanding balance under the Note of $97,126 was repaid at the closing of the Initial Public Offering on July 27, 2020. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Sponsor makes any Working Capital Loans, such loans may be converted into warrants, at the price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds held in the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not completed, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.

Commitments

Commitments	7 Months Ended
	Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 7. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on July 23, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of $6,900,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $12,075,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreement On July 2, 2020, the Company entered into a forward purchase agreement pursuant to which East Asset Management, LLC (“East Asset Management”), an affiliate of the Sponsor, has agreed to purchase an aggregate of up to 5,000,000 units (the “forward purchase units”), consisting of one share of Class A common stock (the “forward purchase shares”) and one-half of one warrant to purchase one share of Class A common stock (the “forward purchase warrants”), for $10.00 per unit, or an aggregate maximum amount of $50,000,000, in a private placement that will close simultaneously with the closing of a Business Combination. East Asset Management will purchase a number of forward purchase units that will result in gross proceeds to the Company necessary to enable the Company to consummate a Business Combination and pay related fees and expenses, after first applying amounts available to the Company from the Trust Account (after paying the deferred underwriting discount and giving effect to any redemptions of Public Shares) and any other financing source obtained by the Company for such purpose at or prior to the consummation of a Business Combination, plus any additional amounts mutually agreed by the Company and East Asset Management to be retained by the post-business combination company for working capital or other purposes. East Asset Management’s obligation to purchase forward purchase units will, among other things, be conditioned on the Business Combination (including the target assets or business, and the terms of the Business Combination) being reasonably acceptable to East Asset Management and on a requirement that such initial Business Combination is approved by a unanimous vote of the Company’s board of directors. In determining whether a target is reasonably acceptable to East Asset Management, the Company expects that East Asset Management would consider many of the same criteria as the Company will consider but will also consider whether the investment is an appropriate investment for East Asset Management.

Stockholders' Equity

Stockholders' Equity	7 Months Ended
	Dec. 31, 2020
Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 8. STOCKHOLDERS’ EQUITY Preferred Stock —The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company's board of directors. As of December 31, 2020, there were no shares of preferred stock issued or outstanding. Class A Common Stock —The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2020, there was 0 shares of Class A common stock issued and outstanding, excluding 34,500,000 shares of Class A common stock subject to possible redemption. Class B Common Stock —The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. As of December 31, 2020, there was 8,625,000 shares of Class B common stock issued and outstanding. Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders, except as required by law. The Class B common stock are identical to the shares of Class A common stock included in the Units sold in the Initial Public Offering, and holders of Class B common stock have the same stockholder rights as public stockholders, except that (i) the Class B common stock are subject to certain transfer restrictions, as described in more detail below, (ii) the Sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed (A) to waive their redemption rights with respect to any Class B common stock and any Public Shares held by them in connection with the completion of a Business Combination and (B) to waive their rights to liquidating distributions from the Trust Account with respect to any Class B common stock held by them if the Company fails to complete a Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete our Business Combination within the Combination Period, (iii) the Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination, on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights and (iv) are subject to registration rights. If the Company submits a Business Combination to the public stockholders for a vote, the Sponsor has agreed to vote any Class B common stock held by it and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. With certain limited exceptions, the shares of Class B common stock are not transferable, assignable or salable (except to the Company’s officers and directors and other persons or entities affiliated with the Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Warrant Liability

Warrant Liability	7 Months Ended
	Dec. 31, 2020
Warrants And Rights Note Disclosure [Abstract]
WARRANT LIABILITY	NOTE 9. WARRANT LIABILITY Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed Offering. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. Redemption of Warrants for Cash —Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. Redemption of Warrants for Shares of Class A Common Stock —Once the warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock: • in whole and not in part; • at a price equal to a number of shares of Class A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the “fair market value” of the Class A common stock; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described above adjacent to “Redemption of Warrants For Cash” and “Redemption of Warrants For Shares of Class A Common Stock” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Income Tax

Income Tax	7 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAX	NOTE 10. INCOME TAX The Company’s net deferred tax assets are as follows: December 31, 2020 Deferred tax assets Net operating loss carryforward $ 20,227 Startup and organizational expenses 74,400 Total deferred tax assets 94,627 Valuation Allowance (94,627 ) Deferred tax assets, net of allowance $ — The income tax provision consists of the following: For the Period from May 22, 2020 December 31, 2020 Federal Current $ — Deferred (94,627 ) State and Local Current — Deferred — Change in valuation allowance 94,627 Income tax provision $ — As of December 31, 2020, the Company had $450,605 of U.S. federal net operating loss carryovers available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from , the change in the valuation allowance was $94,627. A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: December 31, 2020 Statutory federal income tax rate 21.0 % State taxes, net of federal tax benefit 0.0 % Change in fair value of warrants (14.8 )% Change in fair value of forward purchase agreement liability (3.7 )% Transaction costs allocable to warrants (1.7 )% Valuation allowance (0.8 )% Income tax provision 0.0 % The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company's tax returns since inception remain open to examination by the taxing authorities. The Company considers Florida

Fair Value Measurements

Fair Value Measurements	7 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 11. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 345,026,104 Liabilities: Warrant Liability – Public Warrants 1 $ 19,665,000 Warrant Liability – Private Placement Warrants 3 $ 10,146,000 Forward Purchase Agreement Liability 3 $ 2,900,000 The Warrants and forward purchase agreement were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the balance sheet. The warrant liabilities and forward purchase agreement liability are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statement of operations. The Warrants were valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units was classified as Level 1 due to the use of an observable market quote in an active market. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. The following table presents the quantitative information regarding Level 3 fair value measurements of the warrant liabilities: December 31, 2020 July 27, 2020 (Initial measurement) Unit price $ 10.15 $ 10.18 Term to initial business combination (in years) 1.0 1.4 Volatility 15.6 % 14.0 % Risk-free rate 0.51 % 0.41 % Dividend yield 0.0 % 0.0 % The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Public Level 3 Warrant Liabilities Fair value as of May 22, 2020 (inception) $ — $ — $ — Initial measurement on July 27, 2020 (including overallotment) 7,565,000 14,662,500 22,227,500 Change in fair value 2,581,000 5,002,500 7,583,500 Transfers out of level 3 — (19,665,000 ) (19,665,000 ) Fair value as of December 31, 2020 $ 10,146,000 $ — $ 10,146,000 The forward purchase agreement was valued using the publicly traded price of the Company’s Units, based upon the fact that the Forward Purchase Units are equivalent to the Company’s publicly traded Units, and the publicly traded price of the Units considered (i) the market’s expectation of an initial Business Combination and (ii) the Company’s redemption of the common stock within the Units at $10.00 per shares if an initial Business Combination does not occur. The following table presents the changes in the fair value of forward purchase agreement liability: Fair value as of May 22, 2020 (inception) $ — Initial measurement on July 27, 2020 1,000,000 Change in fair value 1,900,000 Fair value as of December 31, 2020 $ 2,900,000 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the period from May 22, 2020 through December 31, 2020 was $19,665,000.

Subsequent Events

Subsequent Events	7 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12. SUBSEQUENT EVENTS The Company evaluates subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below and in Note 2 On February 15, 2021, the Sponsor committed to provide the Company an aggregate of $500,000 in loans for working capital purposes.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	7 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. The Company’s derivative instruments are recorded at fair value and re-valued at each reporting date, with changes in the fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants and the forward contract for additional warrants are derivatives. As the financial instruments meet the definition of a derivative the warrants and the forward contract for additional warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the Statement of Operations in the period of change.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.
Net Loss per Common Share	Net Loss per Common Share Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 26,150,000 shares in the calculation of diluted loss per share, since the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to possible redemption outstanding since original issuance. Net income (loss) per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of non-redeemable common stock outstanding for the period. Non-redeemable common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period from May 22, 2020 (Inception) Through December 31, 2020 Class A common stock subject to possible redemption Numerator: Earnings allocable to common stock subject to possible redemption Interest earned and unrealized gain $ 26,104 Less: interest available to be withdrawn for payment of taxes (26,104 ) Net income attributable to Class A common stock subject to $ — Denominator: Weighted Average Class A common stock subject to possible Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 33,668,790 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable common stock Numerator: Net Loss minus Net Earnings Net loss $ ( 10,795,459 ) Less: Net income allocable to Class A Common stock subject to possible redemption — Non-Redeemable Net Loss $ ( 10,795,459 ) Denominator: Weighted Average Non-Redeemable common stock Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,145,740 Basic and diluted net loss per share, Non-redeemable common stock $ ( 1.33 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Fair Value Measurements	Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	7 Months Ended
	Dec. 31, 2020
Accounting Changes And Error Corrections [Abstract]
Summary of Restated Financial Statements	The table below summarizes the effects of the restatement on the financial statements for all periods being restated: As Previously As Reported Adjustments Restated Balance sheet as of July 27, 2020 (audited) Warrant Liability $ — $ 19,550,000 $ 19,550,000 Forward purchase agreement liability — 1,000,000 1,000,000 Class A Common Stock Subject to Possible Redemption 285,659,360 59,340,640 345,000,000 Class A Common Stock 143 (143 ) — Additional Paid-in Capital 4,999,463 (4,975,326 ) 24,137 Accumulated Deficit (468 ) (74,915,171 ) (74,915,639 ) Number of Class A common stock subject to possible redemption 28,565,936 5,934,064 34,500,000 Balance sheet as of September 30, 2020 (unaudited) Warrant Liability $ — $ 16,736,000 $ 16,736,000 Forward purchase agreement liability — 550,000 550,000 Class A Common Stock Subject to Possible Redemption 328,955,750 16,044,250 345,000,000 Class A Common Stock 160 (160 ) — Additional Paid-in Capital 5,128,056 (5,103,919 ) 24,137 Accumulated Deficit (129,076 ) (28,226,171 ) (28,355,247 ) Number of Class A common stock subject to possible redemption 32,895,575 1,604,425 34,500,000 Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 29,811,000 $ 29,811,000 Forward purchase agreement liability — 2,900,000 2,900,000 Class A Common Stock Subject to Possible Redemption 328,634,220 16,365,780 345,000,000 Class A Common Stock 164 (164 ) — Additional Paid-in Capital 5,449,582 5,425,445 24,137 Accumulated Deficit (450,605 ) (43,651,171 ) (44,101,776 ) Number of Class A common stock subject to possible redemption 32,863,422 1,636,578 34,500,000 Statement of Operations for period from May 22, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 5,491,500 $ 5,491,500 Change in fair value of forward purchase agreement liability $ — $ 450,000 $ 450,000 Transaction costs allocable to warrants $ — $ (861,354 ) $ (861,354 ) Net income (loss) $ (129,076 ) $ 5,080,146 $ 4,951,070 Weighted average shares outstanding of Class A redeemable common stock 30,971,013 1,521,295 32,492,308 Basic and diluted net income per share, Class A redeemable common stock $ 0.00 — $ 0.00 Weighted average shares outstanding of non-redeemable common stock 8,564,001 (754,841 ) 7,809,160 Basic and diluted net (loss) income per share, non-redeemable common stock $ (0.02 ) 0.65 $ 0.63 Statement of Operations for period from May 22, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ (7,583,500 ) $ (7,583,500 ) Change in fair value of forward purchase agreement liability $ — $ (1,900,000 ) $ (1,900,000 ) Transaction costs allocable to warrants $ — $ (861,354 ) $ (861,354 ) Net loss $ (450,605 ) $ (10,344,854 ) $ (10,795,459 ) Weighted average shares outstanding of Class A redeemable common stock 32,098,782 1,570,008 33,668,790 Basic and diluted net income per share, Class A redeemable common stock $ 0.00 — $ 0.00 Weighted average shares outstanding of non-redeemable common stock 9,251,082 (1,105,342 ) 8,145,740 Basic and diluted net loss per share, non-redeemable common stock $ (0.05 ) (1.28 ) $ (1.33 ) Statement of Cash Flows for period from May 22, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ (5,491,500 ) $ (5,491,500 ) Change in fair value of forward purchase agreement liability — (450,000 ) (450,000 ) Transaction costs allocable to warrants — 861,354 861,354 Net income (loss) (129,076 ) 4,080,146 4,951,070 Initial classification of Class A common stock subject to possible redemption 329,084,360 15,915,640 345,000,000 Change in value of common stock subject to possible redemption (128,610 ) 128,610 — Statement of Cash Flows for period from May 22, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ 7,583,500 $ 7,583,500 Change in fair value of forward purchase agreement liability — 1,900,000 1,900,000 Transaction costs allocable to warrants — 861,354 861,354 Net loss (450,605 ) (10,344,854 ) (10,795,459 ) Initial classification of Class A common stock subject to possible redemption 329,084,360 15,915,640 345,000,000 Change in value of common stock subject to possible redemption (450,140 ) 450,140 —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	7 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Calculation of Basic and Diluted Net Income (Loss) per Common Share	The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period from May 22, 2020 (Inception) Through December 31, 2020 Class A common stock subject to possible redemption Numerator: Earnings allocable to common stock subject to possible redemption Interest earned and unrealized gain $ 26,104 Less: interest available to be withdrawn for payment of taxes (26,104 ) Net income attributable to Class A common stock subject to $ — Denominator: Weighted Average Class A common stock subject to possible Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 33,668,790 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable common stock Numerator: Net Loss minus Net Earnings Net loss $ ( 10,795,459 ) Less: Net income allocable to Class A Common stock subject to possible redemption — Non-Redeemable Net Loss $ ( 10,795,459 ) Denominator: Weighted Average Non-Redeemable common stock Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,145,740 Basic and diluted net loss per share, Non-redeemable common stock $ ( 1.33 )

Income Tax (Tables)

Income Tax (Tables)	7 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Net Deferred Tax Assets	The Company’s net deferred tax assets are as follows: December 31, 2020 Deferred tax assets Net operating loss carryforward $ 20,227 Startup and organizational expenses 74,400 Total deferred tax assets 94,627 Valuation Allowance (94,627 ) Deferred tax assets, net of allowance $ —
Summary of Income Tax Provision	The income tax provision consists of the following: For the Period from May 22, 2020 December 31, 2020 Federal Current $ — Deferred (94,627 ) State and Local Current — Deferred — Change in valuation allowance 94,627 Income tax provision $ —
Reconciliation of Federal Income Tax Rate	A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: December 31, 2020 Statutory federal income tax rate 21.0 % State taxes, net of federal tax benefit 0.0 % Change in fair value of warrants (14.8 )% Change in fair value of forward purchase agreement liability (3.7 )% Transaction costs allocable to warrants (1.7 )% Valuation allowance (0.8 )% Income tax provision 0.0 %

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	7 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of Information about Assets and Liabilities that are Measured at Fair Value on a Recurring Basis and Fair Value Hierarchy of Valuation Inputs Utilized	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 345,026,104 Liabilities: Warrant Liability – Public Warrants 1 $ 19,665,000 Warrant Liability – Private Placement Warrants 3 $ 10,146,000 Forward Purchase Agreement Liability 3 $ 2,900,000
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements of Warrant Liabilities	The following table presents the quantitative information regarding Level 3 fair value measurements of the warrant liabilities: December 31, 2020 July 27, 2020 (Initial measurement) Unit price $ 10.15 $ 10.18 Term to initial business combination (in years) 1.0 1.4 Volatility 15.6 % 14.0 % Risk-free rate 0.51 % 0.41 % Dividend yield 0.0 % 0.0 %
Summary of Changes in Fair Value of Level 3 Warrant Liabilities and Forward Purchase Agreement Liability	The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Public Level 3 Warrant Liabilities Fair value as of May 22, 2020 (inception) $ — $ — $ — Initial measurement on July 27, 2020 (including overallotment) 7,565,000 14,662,500 22,227,500 Change in fair value 2,581,000 5,002,500 7,583,500 Transfers out of level 3 — (19,665,000 ) (19,665,000 ) Fair value as of December 31, 2020 $ 10,146,000 $ — $ 10,146,000 The following table presents the changes in the fair value of forward purchase agreement liability: Fair value as of May 22, 2020 (inception) $ — Initial measurement on July 27, 2020 1,000,000 Change in fair value 1,900,000 Fair value as of December 31, 2020 $ 2,900,000

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Details) - USD ($)	Jul. 23, 2021	Aug. 25, 2020	Dec. 31, 2020
Description Of Organization And Business Operations [Line Items]
Sale of stock, transaction date		Aug. 25, 2020
Sale of units, net of underwriting discounts, offering costs and public warranty			34,500,000
Sale of stock, price per share		$ 10	$ 18
Sale of warrants, exercise price per share			$ 0.01
Proceeds from issuance of Class B common stock to Sponsor			$ 25,000
Total cash deposited into the Trust Account		$ 45,000,000
Aggregate proceeds held in the Trust Account		345,000,000
Transaction costs		19,840,171
Underwriting fees		6,900,000
Deferred underwriting fees		12,075,000
Other offering costs		$ 865,171
Business combination terms and description			The Company will have until July 27, 2022 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
Percentage of redemption of company's outstanding public shares			100.00%
Maximum
Description Of Organization And Business Operations [Line Items]
Open-ended investment holding maturity period		185 days
Interest to pay for dissolution expenses			$ 100,000
Minimum
Description Of Organization And Business Operations [Line Items]
Percentage of initial business combination fair market value of net assets held in trust account			80.00%
Percentage of ownership required to complete business combination			50.00%
Net tangible assets required for business combination			$ 5,000,001
Class A common stock
Description Of Organization And Business Operations [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty			34,500,000
Class A common stock | Minimum
Description Of Organization And Business Operations [Line Items]
Sale of stock, price per share			$ 10
Initial Public Offering
Description Of Organization And Business Operations [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty		34,500,000
Initial Public Offering | Class A common stock
Description Of Organization And Business Operations [Line Items]
Sale of stock, transaction date	Jul. 27, 2020
Sale of units, net of underwriting discounts, offering costs and public warranty	30,000,000
Sale of stock, price per share	$ 10	$ 10
Gross proceeds from issuance stock	$ 300,000,000
Private Placement Warrants
Description Of Organization And Business Operations [Line Items]
Sale of warrants	8,000,000	900,000
Sale of warrants, exercise price per share	$ 1	$ 1
Gross proceeds from sale of warrants	$ 8,000,000	$ 900,000
Over-Allotment Option
Description Of Organization And Business Operations [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty		4,500,000
Proceeds from issuance of Class B common stock to Sponsor		$ 45,000,000
Initial Public Offering and Private Placement Warrants
Description Of Organization And Business Operations [Line Items]
Aggregate proceeds held in the Trust Account		$ 345,000,000

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Summary of Restated Balance Sheet (Details) - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Jul. 27, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Warrant liability	$ 29,811,000	$ 16,736,000	$ 19,550,000
Forward purchase agreement liability	2,900,000	550,000	1,000,000
Additional paid-in capital	24,137	24,137	24,137
Accumulated deficit	(44,101,776)	(28,355,247)	(74,915,639)
Class A common stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Class A Common Stock Subject to Possible Redemption	$ 345,000,000	$ 345,000,000	$ 345,000,000
Number of Class A common stock subject to possible redemption	34,500,000	34,500,000	34,500,000
As Previously Reported
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Additional paid-in capital	$ 5,449,582	$ 5,128,056	$ 4,999,463
Accumulated deficit	(450,605)	(129,076)	(468)
As Previously Reported | Class A common stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Class A Common Stock Subject to Possible Redemption	328,634,220	328,955,750	285,659,360
Common stock value	$ 164	$ 160	$ 143
Number of Class A common stock subject to possible redemption	32,863,422	32,895,575	28,565,936
Adjustments
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Warrant liability	$ 29,811,000	$ 16,736,000	$ 19,550,000
Forward purchase agreement liability	2,900,000	550,000	1,000,000
Additional paid-in capital	5,425,445	(5,103,919)	(4,975,326)
Accumulated deficit	(43,651,171)	(28,226,171)	(74,915,171)
Adjustments | Class A common stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Class A Common Stock Subject to Possible Redemption	16,365,780	16,044,250	59,340,640
Common stock value	$ (164)	$ (160)	$ (143)
Number of Class A common stock subject to possible redemption	1,636,578	1,604,425	5,934,064

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Summary of Restated Statements of Operations (Details) - USD ($)	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Change in fair value of warrant liability	$ 5,491,500	$ (7,583,500)
Change in fair value of forward purchase agreement liability	450,000	(1,900,000)
Transaction costs allocable to warrants	(861,354)	(861,354)
Net income (loss)	$ 4,951,070	$ (10,795,459)
Class A Common to Redemption
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	32,492,308	33,668,790
Basic and diluted net income (loss) per share	$ 0	$ 0
Non-redeemable Preferred Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	7,809,160	8,145,740
Basic and diluted net income (loss) per share	$ 0.63	$ (1.33)
As Previously Reported
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ (129,076)	$ (450,605)
As Previously Reported | Class A Common to Redemption
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	30,971,013	32,098,782
Basic and diluted net income (loss) per share	$ 0	$ 0
As Previously Reported | Non-redeemable Preferred Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	8,564,001	9,251,082
Basic and diluted net income (loss) per share	$ (0.02)	$ (0.05)
Adjustments
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Change in fair value of warrant liability	$ 5,491,500	$ (7,583,500)
Change in fair value of forward purchase agreement liability	450,000	(1,900,000)
Transaction costs allocable to warrants	(861,354)	(861,354)
Net income (loss)	$ 5,080,146	$ (10,344,854)
Adjustments | Class A Common to Redemption
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	1,521,295	1,570,008
Adjustments | Non-redeemable Preferred Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	(754,841)	(1,105,342)
Basic and diluted net income (loss) per share	$ 0.65	$ (1.28)

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Summary of Restated Statement of Cash Flows (Details) - USD ($)	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Change in fair value of warrant liability	$ (5,491,500)	$ 7,583,500
Change in fair value of forward purchase agreement liability	(450,000)	1,900,000
Transaction costs allocable to warrants	861,354	861,354
Net income (loss)	4,951,070	(10,795,459)
Class A common stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Initial classification of Class A common stock subject to possible redemption	345,000,000	345,000,000
As Previously Reported
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income (loss)	(129,076)	(450,605)
Change in value of common stock subject to possible redemption	(128,610)	(450,140)
As Previously Reported | Class A common stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Initial classification of Class A common stock subject to possible redemption	329,084,360	329,084,360
Adjustments
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Change in fair value of warrant liability	(5,491,500)	7,583,500
Change in fair value of forward purchase agreement liability	(450,000)	1,900,000
Transaction costs allocable to warrants	861,354	861,354
Net income (loss)	4,080,146	(10,344,854)
Change in value of common stock subject to possible redemption	128,610	450,140
Adjustments | Class A common stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Initial classification of Class A common stock subject to possible redemption	$ 15,915,640	$ 15,915,640

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)	7 Months Ended
	Dec. 31, 2020USD ($)shares
Summary Of Significant Accounting Policies [Line Items]
Cash equivalents	$ 0
Unrecognized tax benefits	0
Amounts accrued for interest and penalties	0
Federal Depository Insurance Coverage amount	$ 250,000
Warrants | Common Stock
Summary Of Significant Accounting Policies [Line Items]
Antidilutive securities excluded calculation of diluted loss per share | shares	26,150,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Income (Loss) per Common Share (Details) - USD ($)	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
Numerator: Earnings allocable to common stock subject to possible redemption
Net loss	$ 4,951,070	$ (10,795,459)
Interest earned and unrealized gain on marketable securities held in Trust Account		26,104
Numerator: Net Loss minus Net Earnings
Net loss		(10,795,459)
Non-Redeemable Net Loss		$ (10,795,459)
Denominator: Weighted Average Non-Redeemable common stock
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		8,145,740
Basic and diluted net loss per share, Non-redeemable common stock		$ (1.33)
Class A common stock
Numerator: Earnings allocable to common stock subject to possible redemption
Less: interest available to be withdrawn for payment of taxes		$ (26,104)
Denominator: Weighted Average Class A common stock subject to possible redemption
Basic and diluted weighted average shares outstanding		33,668,790
Basic and diluted net loss per share		$ 0

Public Offering - Additional In

Public Offering - Additional Information (Details) - $ / shares	Jul. 23, 2021	Aug. 25, 2020	Dec. 31, 2020
Subsidiary Sale Of Stock [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty			34,500,000
Sale of stock, price per share		$ 10	$ 18
Sale of stock, transaction date		Aug. 25, 2020
Class A common stock
Subsidiary Sale Of Stock [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty			34,500,000
Number of share holding in each class of warrant		1
Shares issued, price per share		$ 11.50
Initial Public Offering
Subsidiary Sale Of Stock [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty		34,500,000
Initial Public Offering | Class A common stock
Subsidiary Sale Of Stock [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty	30,000,000
Sale of stock, price per share	$ 10	$ 10
Sale of stock, transaction date	Jul. 27, 2020
Over-Allotment Option
Subsidiary Sale Of Stock [Line Items]
Sale of units, net of underwriting discounts, offering costs and public warranty		4,500,000

Private Placement - Additional

Private Placement - Additional Information (Details) - USD ($)	7 Months Ended
	Dec. 31, 2020	Jul. 23, 2021	Aug. 25, 2020
Subsidiary Sale Of Stock [Line Items]
Issuance of Class B common stock to Sponsors	$ 25,000
Sale of warrants, exercise price per share	$ 0.01
Class A common stock
Subsidiary Sale Of Stock [Line Items]
Shares issued, price per share			$ 11.50
Private Placement Warrants
Subsidiary Sale Of Stock [Line Items]
Sale of warrants, exercise price per share		$ 1	$ 1
Private Placement Warrants | Warrants
Subsidiary Sale Of Stock [Line Items]
Issuance of Class B common stock to Sponsors, shares	8,900,000
Shares issued, price per share	$ 1
Issuance of Class B common stock to Sponsors	$ 8,900,000
Private Placement Warrants | Warrants | Class A common stock
Subsidiary Sale Of Stock [Line Items]
Sale of warrants, exercise price per share	$ 11.50
Each warrant exercisable	1

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details)	Aug. 25, 2020$ / sharesshares	Jul. 27, 2020USD ($)	Jul. 24, 2020USD ($)Affiliate	Jun. 01, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Jun. 24, 2020USD ($)
Related Party Transaction [Line Items]
Sponsor purchased aggregate price					$ 25,000
Number of affiliates | Affiliate			2
Fees paid under office space and administrative support services					105,161
Advances outstanding						$ 265,763
Repayments of advances from related party		$ 265,763
Promissory note outstanding						$ 300,000
Repayments of related party		$ 97,126			$ 97,126
Warrant conversion price | $ / shares					$ 1.50
Affiliate One
Related Party Transaction [Line Items]
Monthly amount paid to affiliates of sponsor for office space and administrative support services			$ 10,000
Affiliate Two
Related Party Transaction [Line Items]
Monthly amount paid to affiliates of sponsor for office space and administrative support services			$ 10,000
Class B common stock
Related Party Transaction [Line Items]
Sponsor purchased shares | shares				8,625,000	8,625,000
Shares issued, price per share | $ / shares				$ 0.0001
Sponsor purchased aggregate price				$ 25,000	$ 863
Founders share subject to forfeiture | shares				1,125,000
Percentage of issued and outstanding				20.00%
Shares exercises in period | shares	1,125,000
Class A common stock
Related Party Transaction [Line Items]
Shares issued, price per share | $ / shares	$ 11.50
Stockholders' equity stock split, conversion ratio				1

Commitments - Additional Inform

Commitments - Additional Information (Details) - USD ($)	7 Months Ended
	Dec. 31, 2020	Jul. 02, 2020
Forward Purchase Agreement
Loss Contingencies [Line Items]
Maximum number of forward purchase units to be purchased by affiliate		5,000,000
Number of shares issued consists per units purchased under agreement		1
Number of warrants issued consist per units purchased under agreement		0.5
Forward Purchase Agreement | Class A common stock
Loss Contingencies [Line Items]
Forward purchase warrants per share		$ 10
Maximum amount of forward purchase warrants in private placement		$ 50,000,000
Each warrant exercisable		1
Underwriting Agreement
Loss Contingencies [Line Items]
Payments to underwriters as underwriting discount	$ 6,900,000
Underwriters entitled for deferred fee	$ 12,075,000
Underwriters entitled for deferred fee per unit	$ 0.35

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details)	7 Months Ended
	Dec. 31, 2020$ / sharesshares
Class Of Stock [Line Items]
Preferred stock, shares authorized	1,000,000
Preferred stock, par value | $ / shares	$ 0.0001
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Common stock voting rights	one vote
Class A common stock
Class Of Stock [Line Items]
Common stock, shares authorized	200,000,000
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares, issued	0
Common stock, shares, outstanding	0
Common stock subject to possible redemption	34,500,000
Common stock last sale price per share equals or exceeds as adjusted for stock splits, stock dividends, reorganizations and recapitalizations | $ / shares	$ 12
Common stock last sale price equals or exceeds as adjusted for stock splits, stock dividends, reorganizations and recapitalizations for any trading days	20 days
Common stock last sale price equals or exceeds as adjusted for stock splits, stock dividends, reorganizations and recapitalizations with in trading day period	30 days
Common stock last sale price equals or exceeds as adjusted for stock splits, stock dividends, reorganizations and recapitalizations minimum commencing period after business combination	150 days
Class B common stock
Class Of Stock [Line Items]
Common stock, shares authorized	20,000,000
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares, issued	8,625,000
Common stock, shares, outstanding	8,625,000
Common stock, conversion basis	one-for-one
Common stock transferable assignable or salable period after completion of business combination	1 year

Warrant Liability - Additional

Warrant Liability - Additional Information (Details) - USD ($)	7 Months Ended
	Dec. 31, 2020	Aug. 25, 2020
Class Of Warrant Or Right [Line Items]
Number of fractional shares issued upon exercise of public warrants	0
Public warrants exercisable period after completion of business combination	30 days
Public warrants exercisable period from closing of proposed offering	12 months
Public warrants expiration term after completion of business combination	5 years
Obligation to settle public warrant exercise	$ 0
Warrants exercisable	$ 0
Sale of warrants, exercise price per share	$ 0.01
Minimum period prior written notice of redemption to each warrant holder	30 days
Sale of stock, price per share	$ 18	$ 10
Warrants redemption terms	the last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
Adjustment of warrant exercise price, description	the volume weighted average trading price of the Company’s shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price
Adjusted percentage of higher of the market value and the newly issued price for redemption of warrants for cash	100.00%
Class A common stock
Class Of Warrant Or Right [Line Items]
Minimum period prior written notice of redemption to each warrant holder	30 days
Warrants redemption terms	the last sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
Percentage of equity proceeds and interest.	60.00%
Adjusted percentage of higher of the market value and the newly issued price for redemption of warrants for shares of Class A common stock	180.00%
Class A common stock | Minimum
Class Of Warrant Or Right [Line Items]
Sale of stock, price per share	$ 10
Class A common stock | Maximum
Class Of Warrant Or Right [Line Items]
Effective issue price per share	$ 9.20

Income Tax - Schedule of Net De

Income Tax - Schedule of Net Deferred Tax Assets (Details)	Dec. 31, 2020USD ($)
Deferred tax assets
Net operating loss carryforward	$ 20,227
Startup and organizational expenses	74,400
Total deferred tax assets	94,627
Valuation Allowance	$ (94,627)

Income Tax - Summary of Income

Income Tax - Summary of Income Tax Provision (Details)	7 Months Ended
	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Deferred	$ (94,627)
Change in valuation allowance	$ 94,627

Income Tax - Additional Informa

Income Tax - Additional Information (Details)	7 Months Ended
	Dec. 31, 2020USD ($)
Income Tax [Line Items]
Change in valuation allowance	$ 94,627
Federal
Income Tax [Line Items]
Net operating loss carryovers	$ 450,605

Income Tax - Reconciliation of

Income Tax - Reconciliation of Federal Income Tax Rate (Details)	7 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	21.00%
State taxes, net of federal tax benefit	0.00%
Change in fair value of warrants	(14.80%)
Change in fair value of forward purchase agreement liability	(3.70%)
Transaction costs allocable to warrants	(1.70%)
Valuation allowance	(0.80%)
Income tax provision	0.00%

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Information about Assets that are Measured at Fair Value on a Recurring Basis and Fair Value Hierarchy of Valuation Inputs Utilized (Details) - Fair Value Measurements, Recurring	Dec. 31, 2020USD ($)
Level 1 | Warrant Liability – Public Warrants
Liabilities:
Liabilities	$ 19,665,000
Level 1 | Marketable Securities
Assets:
Marketable securities held in Trust Account	345,026,104
Level 3 | Warrant Liability – Private Placement Warrants
Liabilities:
Liabilities	10,146,000
Level 3 | Forward Purchase Agreement
Liabilities:
Liabilities	$ 2,900,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Quantitative Information Regarding Fair Value Assumptions (Details) - Level 3	Dec. 31, 2020	Jul. 27, 2020
Unit Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	10.15	10.18
Term to Initial Business Combination
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, term	1 year	1 year 4 months 24 days
Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	15.60	14
Risk-free Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.51	0.41
Dividend Yield
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0	0

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Changes in Fair Value of Level 3 Warrant Liabilities and Forward Purchase Agreement Liability (Details) - USD ($)	7 Months Ended
	Dec. 31, 2020	Jul. 27, 2020
Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Initial measurement on July 27, 2020 (including overallotment)		$ 22,227,500
Change in fair value	$ 7,583,500
Transfers out of level 3	(19,665,000)
Ending balance	10,146,000
Warrant Liability – Private Placement Warrants
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Initial measurement on July 27, 2020 (including overallotment)		7,565,000
Change in fair value	2,581,000
Ending balance	10,146,000
Warrant Liability – Public Warrants
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Initial measurement on July 27, 2020 (including overallotment)		14,662,500
Change in fair value	5,002,500
Transfers out of level 3	(19,665,000)
Forward Purchase Agreement
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Initial measurement on July 27, 2020 (including overallotment)		$ 1,000,000
Change in fair value	1,900,000
Ending balance	$ 2,900,000

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	Dec. 31, 2020USD ($)$ / shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Redemption price per share | $ / shares	$ 10
Warrant Liability – Public Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair value of Public warrant liability transfer from Level 3 to Level1 | $	$ 19,665,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Details)	Feb. 15, 2021USD ($)
Subsequent Event
Subsequent Event [Line Items]
Loans from sponsor for working capital purposes	$ 500,000